How to get genetic Testing: The CMT Genie

by Courtney | Sep 10, 2022 | 0 comments

Trying to get a genetic confirmation of CMT can be overwhelming, and you might not have access to healthcare providers who are familiar with all the choices out there. HNF’s CMT Genie is designed to assist you and your healthcare provider in determining what the best option is for you! Learn how HNF has teamed up with Genome Medical to provide virtual genetic counseling and fast, affordable testing right from your own home! LIVE Q&A with Genome Medical & Estela Lugo.

Learn more on this topic

Are You a Patient With CMT 1A? New Clinical Trial Opportunity Available For You!

by Courtney | Oct 31, 2016 | Clinical Trials, Featured | 9 Comments

For the first time investigators are looking for patients to participate in a pivotal Phase 3 clinical trial of Pharnext’s lead investigational pleodrug, PXT-3003 for the potential treatment of Charcot-Marie-Tooth Disease Type 1A (CMT1A).

CMT and Exercise

by Courtney | Jun 20, 2016 | Featured, PT and Exercise | 6 Comments

HNF wants to help our Inspire members get answers to questions related to Charcot-Marie-Tooth.

Q&A on Genetic Testing with Stephanie Gandomi, M.S., LCGC, of Invitae

by Courtney | Mar 23, 2016 | CMT Update, Genetic Testing | 12 Comments

HNF gets answers to questions on what is genetic testing, cost, family history, what happens to the data.

Greensboro Survey Study for Genetic Counseling and Genetic Testing

by Courtney | May 27, 2015 | Genetic Testing | 6 Comments

The goal of this study was to explore the perceptions and utilization of genetic counseling and testing by people with Charcot-Marie-Tooth (CMT)

Scientific Advisory Board Meeting

by Courtney | Mar 9, 2015 | CMT Update, Featured | 0 Comments

On the 7th of November we convened our scientific advisory board meeting at the HNF offices in NY. We have written a detailed review that has been published and captures all of the discussion and make this freely available to the scientific community.

Pharnext Announces Pleotherapy Proof of Concept in Charcot-Marie-Tooth Disease Type 1A

by Courtney | Dec 19, 2014 | CMT Type - CMT1A, Featured, Pharnext | 12 Comments

PARIS, December 18th, 2014 – Pharnext SAS today announced the proof of concept of its pleotherapy research and development approach based on a proprietary network pharmacology platform that identifies synergic combinations of drugs already approved for other diseases. Indeed, Pharnext’s lead pleodrug, PXT-3003, has shown positive results both in preclinical and Phase 2 clinical studies published today in the Orphanet Journal of Rare Diseases.

WHAT IS CMT

TYPES OF CMT

PATIENT RESOURCES

CMT UPDATES

CMT CONNECT

CMT Research

TRIAD

GRIN PATIENT REGISTRY

PEDIATRICS & CMT

WHAT IS MITO

TYPES OF MITOS

MITO Faces

MITO Research

TRIAD - Mito

GRIN PATIENT REGISTRY

PEDIATRICS & MITO CMT

FDA

CLINICAL TRIALS

PATIENT-FOCUSED RESEARCH

EMERGING TECHNOLOGIES

GENETIC TESTING - CMT GENIE

MOVEMENT IS MEDICINE™

FACES OF CMT

INDUSTRY

HCPs/CENTERS OF EXCELLENCE

RESEARCH FUNDING

About HNF

OUR STORY

FOUNDATION LEADERSHIP

990's & ANNUAL REPORTS

Join Team CMT

Ways to Give

Amazon Wishlist

CMT Shop

GRIN Registry

Facebook Fundraiser

Celebrate your birthday with a purpose

Participate or Host an event

Make A Donation Today

Click here if the donation form does not display below.

How to get genetic Testing: The CMT Genie

Learn more on this topic

Related Blog Posts

Join the conversation

Leave a Comment

0 Comments

Submit a Comment Cancel reply

Newsletter

Join for notifications on events, campaigns, & news

Success!